SCHEMBL2805142

SCHEMBL2805142

CNc1ncc2c(n1)-c1ccccc1C1(CCN(C(C)=O)CC1)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
HDAC3 O15379 2/20 0.40
HDAC2 Q92769 2/20 0.40
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 2/20 0.38
GAA P10253 1/20 0.38
ENPP2 Q13822 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.36
NPY5R Q15761 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MARK3 P27448 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
PTAFR P25105 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806557 0.91 HDAC3 (0.42) HDAC1HDAC6HDAC3HDAC2CYP1A2
SCHEMBL2806554 0.91 HDAC3 (0.42) HDAC1HDAC6HDAC3HDAC2CYP1A2
SCHEMBL2802255 0.89 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19GAAALDH1A1
SCHEMBL2802649 0.87 NPY5R (0.43) HDAC1HDAC6HDAC3HDAC2CYP1A2
SCHEMBL2802647 0.87 NPY5R (0.43) HDAC1HDAC6HDAC3HDAC2CYP1A2
SCHEMBL2805032 0.86 MEN1 (0.41) HDAC1HDAC6HDAC3HDAC2CYP1A2
SCHEMBL2807824 0.86 HTT (0.40) CYP3A4CYP2C19GAAALDH1A1HPGD
SCHEMBL2802862 0.86 CCNA2 (0.43) HDAC1HDAC6TSHRCCNA2CDK2
SCHEMBL2802169 0.86 MAPT (0.43) GAAALDH1A1HPGDKDM4ECCNA2
SCHEMBL2807832 0.85 PKM (0.42) CYP1A2CYP3A4ALDH1A1NPY5RUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HDAC1 1006/4885HDAC6 449/4885HDAC3 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.